Hasil Pencarian - Juha-Matti Savola
- Menampilkan 1 - 4 hasil dari 4
-
1
Pharmacokinetic and Metabolic Profile of Deutetrabenazine (TEV‐50717) Compared With Tetrabenazine in Healthy Volunteers oleh Frank Schneider, Margaret Bradbury, Thomas A. Baillie, David Stamler, Edward Hellriegel, Donna S. Cox, Pippa S. Loupe, Juha‐Matti Savola, Laura Rabinovich‐Guilatt
Diterbitkan 2020-07-01
Artikel -
2
Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington disease oleh Shani Cohen, Zeev Waks, Jordan J. Elm, Mark Forrest Gordon, Igor D. Grachev, Leehee Navon-Perry, Shai Fine, Iris Grossman, Spyros Papapetropoulos, Juha-Matti Savola
Diterbitkan 2018-12-01
Artikel -
3
Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study oleh Robert A. Hauser, Hadas Barkay, Hubert H. Fernandez, Stewart A. Factor, Joohi Jimenez-Shahed, Nicholas Gross, Leslie Marinelli, Amanda Wilhelm, Jessica Alexander, Mark Forrest Gordon, Juha-Matti Savola, Karen E. Anderson
Diterbitkan 2022-02-01
Artikel -
4
Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease oleh Samuel Frank, Karen E. Anderson, Hubert H. Fernandez, Robert A. Hauser, Daniel O. Claassen, David Stamler, Stewart A. Factor, Joohi Jimenez-Shahed, Hadas Barkay, Amanda Wilhelm, Jessica K. Alexander, Nayla Chaijale, Steve Barash, Juha-Matti Savola, Mark Forrest Gordon, Maria Chen
Diterbitkan 2024-04-01
Artikel